For relevant information regarding accepted insurances, please contact this provider directly.
About Minerva Romero Arenas, M.D.
Research
External Relationships
Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.
For relevant information regarding accepted insurances, please contact this provider directly.
About Nima Maghami, M.D., FACS, MSHPEd
Research
External Relationships
Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.
For relevant information regarding accepted insurances, please contact this provider directly.
About Emily Echevarria, M.D.
Research
External Relationships
Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.
For relevant information regarding accepted insurances, please contact this provider directly.
About Emily Schonfeld, M.D.
Research
External Relationships
Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.
Lisa Witkin M.D discusses the pain outcomes registries and how it helps doctors better care for patients. She shares how a registry works, how it collects data and why is it important for quality care to participate in a registry.
On Tuesday, September 8, 2020, between 5pm and 6pm, a Zoom-Conference on Practical Neurology Updates will be offered by three members of the Neurology Department faculty: Dr. Padmaja Kandula on DIAGNOSIS AND MANAGEMENT OF FIRST SEIZURE, Dr. Joseph W. Doria on UTILITY OF VIDEO EEG IN PAROXYSMAL DISORDERS, and Dr. Steven C. Karceski on RECENT ADVANCES IN EPILEPSY MANAGEMENT.
The Weill Cornell Medicine Interstitial Lung Disease (ILD) Program is dedicated to providing comprehensive and personalized care to our patients living with ILD and pulmonary fibrosis. We work with an expert multidisciplinary team of providers to ensure that we provide an accurate diagnosis, offer patients the most up-to-date information about their disease and treatment options, and develop a patient-centered care plan that aligns with our patients’ values and goals.
For proxy access to another account (e.g., a child’s account), please contact the provider’s office. If you are a patient and have a MyChart account already, the office can link the second account to yours. If you are not a patient, you will need to create a Connect account first.
Weill Cornell Medicine’s ability to adapt has been evident throughout the COVID-19 pandemic, as it shifted from becoming an epicenter from COVID-19 patient care, to becoming a site for Stage III clinical trials for a COVID-19 vaccine.
During Phase 3 of a clinical trial, researchers work with between 300 and 3,000 volunteers to test the efficacy of the potential vaccine and monitor patients for possible adverse reactions. Although this phase of study typically takes between one and four years to complete, U.S. Health and Human Services has called on researchers “to accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics” with no compromise to patient safety.
Recorded on August 20, 2020, this episode of the Weill Cornell Medicine Insights webinar series, called “COVID Clinical Trials: Antibodies, Immunity, and Vaccine Development,” brings together expert faculty members who have been on forefront of the medical center’s vaccine trials.
